Määttä M, Soini Y, Liakka A, Autio-Harmainen H
Department of Pathology, University of Oulu, Finland.
Clin Cancer Res. 2000 Jul;6(7):2726-34.
In the present study, we used in situ hybridization to study 36 primary hepatocellular carcinomas (HCCs) and 35 pancreatic adenocarcinomas to analyze the expressions of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 mRNAs. In HCCs, MT1-MMP mRNA was mainly expressed by cancer cells and to a lesser extent by stromal cells. MMP-2 mRNA was expressed predominantly by cells of tumor stroma, whereas MMP-9 mRNA was seen mainly in neoplastic epithelial cells. In pancreatic adenocarcinomas, MT1-MMP and MMP-9 mRNA were seen at moderate levels both in cancer and in stromal cells, whereas MMP-2 mRNA was predominantly expressed by the tumor stroma. Antigens of MMP-2, MMP-9, and MT1-MMP immunolocalized to the neoplastic epithelium and to the stromal cells in both tumor types. In gelatin zymography, increased amounts of latent and active MMP-2 were found in tumor samples of HCC as compared with adjacent nontumorous liver tissue. On the other hand, the latent form of MMP-9 was found in almost equal amounts both in tumor and normal liver samples, but its active form was present only in HCC. Expression of MT1-MMP mRNA had a tendency to be associated with a lower degree of differentiation in HCC, but such association was not noticed in pancreatic tumors. Correlation to the clinical data showed that MT1-MMP expression had a strong statistical association with a poor outcome of patients (P < 0.01). A similar tendency was also observed in pancreatic adenocarcinomas, but the association did not reach statistical significance. MMP-2 and MMP-9 mRNA expression did not have significant correlation with prognosis. The results of this study support the previous suggestions of the importance of MT1-MMP for malignant growth and indicate that increased MT1-MMP mRNA expression by tumor cells in HCCs and pancreatic adenocarcinomas may have prognostic significance.
在本研究中,我们采用原位杂交技术对36例原发性肝细胞癌(HCC)和35例胰腺腺癌进行研究,以分析膜型1基质金属蛋白酶(MT1-MMP)、MMP-2和MMP-9 mRNA的表达情况。在HCC中,MT1-MMP mRNA主要由癌细胞表达,基质细胞表达较少。MMP-2 mRNA主要由肿瘤基质细胞表达,而MMP-9 mRNA主要见于肿瘤上皮细胞。在胰腺腺癌中,MT1-MMP和MMP-9 mRNA在癌细胞和基质细胞中均呈中等水平表达,而MMP-2 mRNA主要由肿瘤基质表达。MMP-2、MMP-9和MT1-MMP的抗原在两种肿瘤类型的肿瘤上皮和基质细胞中均有免疫定位。在明胶酶谱分析中,与相邻的非肿瘤肝组织相比,HCC肿瘤样本中潜伏型和活性型MMP-2的含量增加。另一方面,MMP-9的潜伏型在肿瘤和正常肝样本中的含量几乎相等,但其活性型仅存在于HCC中。MT1-MMP mRNA的表达在HCC中有与低分化程度相关的趋势,但在胰腺肿瘤中未观察到这种相关性。与临床数据的相关性分析显示,MT1-MMP表达与患者预后不良有很强的统计学关联(P<0.01)。在胰腺腺癌中也观察到类似趋势,但该关联未达到统计学显著性。MMP-2和MMP-9 mRNA表达与预后无显著相关性。本研究结果支持先前关于MT1-MMP对恶性生长重要性的观点,并表明HCC和胰腺腺癌中肿瘤细胞MT1-MMP mRNA表达增加可能具有预后意义。